雅本化学 (300261.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−119.1x

Market Cap

CNY 4.69B

MomentumView details →

1D Return

−2.60%

YTD Return

−27.04%

RSI (14)

44.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−119.1x

Market Cap

CNY 4.69B

RSI (14)

44.9

MomentumView details →

1D Return

−2.60%

YTD Return

−27.04%

ProfitabilityView details →

Gross Margin

14.79%

Net Margin

−15.78%

EBITDA Margin

−3.71%

ROE (TTM)

−11.22%

ROA (TTM)

−5.04%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−0.22%

EPS YoY

+9.29%

FCF YoY

−93.14%

Revenue CAGR 3Y

−13.23%

EPS CAGR 3Y

+38.16%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−CNY 0.11

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.77x

Current Ratio

0.85x

Quick Ratio

0.63x

Div Yield

—

Div Rate

—

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

1.30B

Net Income (TTM)

−204.33M

Op. CF (TTM)

156.50M

Next earningsOct 22, 2026 →

Latest newsMore news →

Yaben Chemical announced a share buyback plan of 25 million to 50 million yuan at a price not exceeding 6.89 yuan per share, funded by its own and self-raised funds, for employee stock ownership plans or equity incentives.19h ago

Yabang Chemical announced a proposed private placement of A-shares to raise up to 841 million yuan for innovative pharmaceutical CDMO projects.25d ago

Similar companies

山东矿机002526.SZ 安妮股份002235.SZ 锡装股份001332.SZ 江龙船艇300589.SZ 联域股份001326.SZ 中光学002189.SZ Find similar companies →

Latest newsMore news →

Yaben Chemical announced a share buyback plan of 25 million to 50 million yuan at a price not exceeding 6.89 yuan per share, funded by its own and self-raised funds, for employee stock ownership plans or equity incentives.19h ago Yabang Chemical announced a proposed private placement of A-shares to raise up to 841 million yuan for innovative pharmaceutical CDMO projects.25d ago